Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01828801 · ClinicalTrials.gov registry record
Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study
A clinical trial, sponsored by DePuy Orthopaedics.
- Completed
- Registry status
- 276
- Enrollment target
NCT01828801: Completed study, sponsored by DePuy Orthopaedics.
NCT01828801 is a clinical trial that has completed, run by DePuy Orthopaedics. The registered enrollment target is 276 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01828801 has completed, sponsored by DePuy Orthopaedics.
- COMPLETED
- Registry status
- 276 participants
- Enrollment target
Study Summary
The purpose of this clinical study is to evaluate blood metal ion levels as a function of time of implantation for the Pinnacle Acetabular MoM system.
Primary Outcome
To compare the chromium serum ion levels in the patient population from pre-operatively through 8 years post-operatively in a 1-way ANOVA. This is a cross-sectional study so each time interval (pre-operatively through 8 years post-operatively) will be a different cohort of patients.
Interventions
- DEVICE Pinnacle Metal-on Metal
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2013-03 |
| Est. Completion | 2016-08 |
What the finished NCT01828801 record still lists
NCT01828801 is an observational study that tracks outcomes without assigning an intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Pinnacle Metal-on Metal is the first listed.
NCT01828801 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01828801 about?
NCT01828801 is a clinical study titled "Pinnacle Metal-on-Metal 522 Post-Market Surveillance Study". The purpose of this clinical study is to evaluate blood metal ion levels as a function of time of implantation for the Pinnacle Acetabular MoM system.
What is the current status of trial NCT01828801?
This trial is currently completed. The enrollment target is 276 participants. The study started on 2013-03. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01828801?
The interventions under investigation include: Pinnacle Metal-on Metal (DEVICE).
Who is sponsoring clinical trial NCT01828801?
This trial is sponsored by DePuy Orthopaedics, which has 38 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia